Thomas Heineman

Directeur Technique/Scientifique/R&D chez ONCOLYTICS BIOTECH INC.

Fortune : 552 334 $ au 31/05/2024

Health Technology

Consumer Services

Postes actifs de Thomas Heineman

Sociétés	Poste	Début	Fin
ONCOLYTICS BIOTECH INC.	Directeur Technique/Scientifique/R&D	01/08/2020	-

Sociétés	Poste	Début	Fin
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Corporate Officer/Principal	01/01/2020	01/07/2020
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	01/08/2016	01/01/2020
HALOZYME THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	01/02/2018	01/01/2020
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	01/02/2018	01/01/2020
GSK PLC	Directeur Technique/Scientifique/R&D	01/01/2006	01/08/2016
Saint Louis University School of Medicine	Corporate Officer/Principal	-	-

The University of Chicago

Doctorate Degree

Internationale

Opérationnelle

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sectorielle

Health Technology	6
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Health Technology